+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Niaspan"

Niaspan LP - API Insight, 2022 - Product Thumbnail Image

Niaspan LP - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Niaspan LP- Drug Insight, 2019 - Product Thumbnail Image

Niaspan LP- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Niaspan is a prescription drug used to treat high cholesterol and triglyceride levels in the blood. It is a form of niacin, a type of B vitamin, and is part of a class of drugs known as lipid-lowering agents. Niaspan works by increasing the amount of HDL (good) cholesterol in the blood while decreasing the amount of LDL (bad) cholesterol. It is often used in combination with other cholesterol-lowering medications, such as statins, to help reduce the risk of cardiovascular disease. Niaspan is available in both immediate-release and extended-release forms. The extended-release form is designed to provide a more gradual release of the medication into the bloodstream, which can help reduce the risk of side effects. Niaspan is a widely used drug in the cardiovascular drug market. It is often prescribed to patients with high cholesterol levels who are unable to control their cholesterol levels with diet and exercise alone. It is also used to help reduce the risk of heart attack and stroke in patients with existing cardiovascular disease. Some of the companies in the Niaspan market include Pfizer, AbbVie, Mylan, and Teva Pharmaceuticals. Show Less Read more